{"entity":{"type":"insider","cik":"0001641217","url":"/insider/0001641217","json_url":"/insider/0001641217.json","name":"Huang Dennis Karl","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2019-04-17","last":"2023-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Huang Dennis Karl","source":"filing","n_filings":7,"first_seen":"2019-04-17","last_seen":"2023-03-03"}],"transactions":[{"id":8035501,"accession":"0001209191-23-016043","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-016043","line_url":"/filing/0001209191-23-016043#line-4","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001641217","owner_name":"Huang Dennis Karl","owner_display_name":"Huang Dennis Karl","owner_url":"/insider/0001641217","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":389.0,"shares_display":"389","price_per_share":45.65,"price_display":"45.65","price_state":"stated","total_value":17757.85,"total_display":"17,757.85","total_whole":"17,758","shares_owned_after":75314.0,"shares_owned_after_display":"75,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-03","scope":"insider"},{"id":6845490,"accession":"0001209191-22-015815","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-015815","line_url":"/filing/0001209191-22-015815#line-2","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001641217","owner_name":"Huang Dennis Karl","owner_display_name":"Huang Dennis Karl","owner_url":"/insider/0001641217","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3234.0,"shares_display":"3,234","price_per_share":66.62,"price_display":"66.62","price_state":"stated","total_value":215449.08,"total_display":"215,449.08","total_whole":"215,449","shares_owned_after":36914.0,"shares_owned_after_display":"36,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-01","filed_date":"2022-03-03","scope":"insider"},{"id":4104878,"accession":"0001209191-21-060759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060759","line_url":"/filing/0001209191-21-060759#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001641217","owner_name":"Huang Dennis Karl","owner_display_name":"Huang Dennis Karl","owner_url":"/insider/0001641217","role":"Officer (EVP & Chief Tech Ops Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Tech Ops Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":358.0,"shares_display":"358","price_per_share":81.14,"price_display":"81.14","price_state":"stated","total_value":29048.12,"total_display":"29,048.12","total_whole":"29,048","shares_owned_after":40148.0,"shares_owned_after_display":"40,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-14","filed_date":"2021-10-18","scope":"insider"},{"id":4892460,"accession":"0001209191-21-031390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-031390","line_url":"/filing/0001209191-21-031390#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001641217","owner_name":"Huang Dennis Karl","owner_display_name":"Huang Dennis Karl","owner_url":"/insider/0001641217","role":"Officer (EVP & Chief Tech Ops Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Tech Ops Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":363.0,"shares_display":"363","price_per_share":113.68,"price_display":"113.68","price_state":"stated","total_value":41265.84,"total_display":"41,265.84","total_whole":"41,266","shares_owned_after":40506.0,"shares_owned_after_display":"40,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-06","filed_date":"2021-05-10","scope":"insider"},{"id":5245009,"accession":"0001209191-21-017546","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-017546","line_url":"/filing/0001209191-21-017546#line-3","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001641217","owner_name":"Huang Dennis Karl","owner_display_name":"Huang Dennis Karl","owner_url":"/insider/0001641217","role":"Officer (EVP & Chief Tech Ops Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Tech Ops Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4255.0,"shares_display":"4,255","price_per_share":138.18,"price_display":"138.18","price_state":"stated","total_value":587955.9,"total_display":"587,955.90","total_whole":"587,956","shares_owned_after":40761.0,"shares_owned_after_display":"40,761","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":2444559,"accession":"0001209191-20-055174","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-055174","line_url":"/filing/0001209191-20-055174#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001641217","owner_name":"Huang Dennis Karl","owner_display_name":"Huang Dennis Karl","owner_url":"/insider/0001641217","role":"Officer (EVP & Chief Tech Ops Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Tech Ops Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":262.0,"shares_display":"262","price_per_share":88.0,"price_display":"88.00","price_state":"stated","total_value":23056.0,"total_display":"23,056.00","total_whole":"23,056","shares_owned_after":34699.0,"shares_owned_after_display":"34,699","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-16","scope":"insider"},{"id":9270856,"accession":"0001209191-19-025114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-025114","line_url":"/filing/0001209191-19-025114#line-1","is_derivative":false,"issuer_cik":"0001515673","issuer_name":"Ultragenyx Pharmaceutical Inc.","issuer_ticker":"RARE","issuer_name_source":null,"issuer_url":"/issuer/0001515673","owner_cik":"0001641217","owner_name":"Huang Dennis Karl","owner_display_name":"Huang Dennis Karl","owner_url":"/insider/0001641217","role":"Officer (EVP & Chief Tech Ops Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Tech Ops Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Tech Ops Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":626.0,"shares_display":"626","price_per_share":65.52,"price_display":"65.52","price_state":"stated","total_value":41015.52,"total_display":"41,015.52","total_whole":"41,016","shares_owned_after":21693.0,"shares_owned_after_display":"21,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-05","filed_date":"2019-04-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001515673","name":"Ultragenyx Pharmaceutical Inc.","url":"/issuer/0001515673","role":"Officer","n_filings":7,"first_seen":"2019-04-17","last_seen":"2023-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001641217","retrieved_at":"2026-08-26T06:15:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}